HighVista Strategies’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
33,457
+355
| +1% | +$11.5K | 0.4% | 105 |
|
|
2025
Q1 | $1.25M | Sell |
33,102
-11,559
| -26% | -$436K | 0.48% | 96 |
|
|
2024
Q4 | $3.66M | Hold |
44,661
| – | – | 1.36% | 11 |
|
|
2024
Q3 | $5.1M | Buy |
44,661
+12,348
| +38% | +$1.41M | 1.76% | 3 |
|
|
2024
Q2 | $2.44M | Buy |
32,313
+22,992
| +247% | +$1.74M | 0.89% | 33 |
|
|
2024
Q1 | $637K | Hold |
9,321
| – | – | 0.23% | 109 |
|
|
2023
Q4 | $585K | Sell |
9,321
-1,927
| -17% | -$121K | 0.21% | 113 |
|
|
2023
Q3 | $573K | Sell |
11,248
-3,313
| -23% | -$169K | 0.27% | 92 |
|
|
2023
Q2 | $727K | Sell |
14,561
-5,045
| -26% | -$252K | 0.33% | 80 |
|
|
2023
Q1 | $735K | Hold |
19,606
| – | – | 0.6% | 57 |
|
|
2022
Q4 | $940K | Sell |
19,606
-1,264
| -6% | -$60.6K | 0.56% | 48 |
|
|
2022
Q3 | $501K | Sell |
20,870
-7,095
| -25% | -$170K | 0.29% | 80 |
|
|
2022
Q2 | $609K | Buy |
+27,965
| New | +$609K | 0.37% | 68 |
|